Tivic Health Systems, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
An amendment to a Schedule 13D filing reveals substantial stock sales by 3i, LP and Tumim Stone Capital, LLC, significantly reducing their beneficial ownership in Valion Bio, Inc.
NASDAQ
Valion Bio, Inc. is undergoing a significant leadership transition and potential capital infusion from 3i, involving the termination of its CEO and changes to its Board of Directors.
NASDAQ
3i, LP, a significant shareholder in Valion Bio, Inc., has formally demanded the immediate removal of CEO Michael Handley, citing sustained mismanagement and destruction of shareholder value.